Search

Search Results
Results 10131 - 10140 of 10206 for Brain Cancer
  • Entyvio IV
    Drug - 31 Jul 2025
    Consumer Medicine Information (CMI) about Entyvio IV intended for persons living in Australia.
  • Verzenio
    Drug - 25 Jul 2025
    Consumer Medicine Information (CMI) about Verzenio intended for persons living in Australia.
  • Uremide 40
    Drug - 2 Jun 2025
    Consumer Medicine Information (CMI) about Uremide 40 intended for persons living in Australia.
  • Mozobil
    Drug - 26 May 2025
    Consumer Medicine Information (CMI) about Mozobil intended for persons living in Australia.
  • Celebrex Relief
    Drug - 16 May 2025
    Consumer Medicine Information (CMI) about Celebrex Relief intended for persons living in Australia.
  • Amgevita
    Drug - 13 May 2025
    Consumer Medicine Information (CMI) about Amgevita intended for persons living in Australia.
  • Dilantin
    Drug - 9 May 2025
    Consumer Medicine Information (CMI) about Dilantin intended for persons living in Australia.
  • Mayzent
    Drug - 23 Apr 2025
    Consumer Medicine Information (CMI) about Mayzent intended for persons living in Australia.
  • Celaxib (New Formulation)
    Drug - 17 Apr 2025
    Consumer Medicine Information (CMI) about Celaxib (New Formulation) intended for persons living in Australia.
  • Avonex
    Drug - 8 Apr 2025
    Consumer Medicine Information (CMI) about Avonex (Interferon beta-1a) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback